CSII - Cardiovascular Systems, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 51.27B
Enterprise value 31.05B
Trailing P/E N/A
Forward P/E 1-115.07
PEG ratio (5-yr expected) 1-0.39
Price/sales (ttm)4.85
Price/book (mrq)7.94
Enterprise value/revenue 34.01
Enterprise value/EBITDA 6-140.04

Trading information

Stock price history

Beta (5Y monthly) 1.48
52-week change 3-24.03%
S&P500 52-week change 35.18%
52-week high 355.22
52-week low 326.00
50-day moving average 335.40
200-day moving average 340.08

Share statistics

Avg vol (3-month) 3331.9k
Avg vol (10-day) 3352.26k
Shares outstanding 539.5M
Float 34.24M
% held by insiders 13.28%
% held by institutions 195.36%
Shares short (14 Jun 2020) 41.07M
Short ratio (14 Jun 2020) 42.59
Short % of float (14 Jun 2020) 44.03%
Short % of shares outstanding (14 Jun 2020) 42.76%
Shares short (prior month 14 May 2020) 41.28M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 325 Feb 2009

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin -4.04%
Operating margin (ttm)-4.11%

Management effectiveness

Return on assets (ttm)-3.13%
Return on equity (ttm)-7.45%

Income statement

Revenue (ttm)262.23M
Revenue per share (ttm)7.73
Quarterly revenue growth (yoy)-3.40%
Gross profit (ttm)200.34M
EBITDA -7.5M
Net income avi to common (ttm)-10.6M
Diluted EPS (ttm)-0.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)107.26M
Total cash per share (mrq)3.04
Total debt (mrq)21.42M
Total debt/equity (mrq)14.96
Current ratio (mrq)3.29
Book value per share (mrq)4.06

Cash flow statement

Operating cash flow (ttm)3.88M
Levered free cash flow (ttm)14.12M